1334 related articles for article (PubMed ID: 28982501)
1. Pulmonary Artery Pressure-Guided Management of Patients With Heart Failure and Reduced Ejection Fraction.
Givertz MM; Stevenson LW; Costanzo MR; Bourge RC; Bauman JG; Ginn G; Abraham WT;
J Am Coll Cardiol; 2017 Oct; 70(15):1875-1886. PubMed ID: 28982501
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary Artery Pressure-Guided Heart Failure Management Reduces 30-Day Readmissions.
Adamson PB; Abraham WT; Stevenson LW; Desai AS; Lindenfeld J; Bourge RC; Bauman J
Circ Heart Fail; 2016 Jun; 9(6):. PubMed ID: 27220593
[TBL] [Abstract][Full Text] [Related]
3. Implantable Hemodynamic Monitors Improve Survival in Patients With Heart Failure and Reduced Ejection Fraction.
Lindenfeld J; Costanzo MR; Zile MR; Ducharme A; Troughton R; Maisel A; Mehra MR; Paul S; Sears SF; Smart F; Johnson N; Henderson J; Adamson PB; Desai AS; Abraham WT;
J Am Coll Cardiol; 2024 Feb; 83(6):682-694. PubMed ID: 38325994
[TBL] [Abstract][Full Text] [Related]
4. Interventions Linked to Decreased Heart Failure Hospitalizations During Ambulatory Pulmonary Artery Pressure Monitoring.
Costanzo MR; Stevenson LW; Adamson PB; Desai AS; Heywood JT; Bourge RC; Bauman J; Abraham WT
JACC Heart Fail; 2016 May; 4(5):333-44. PubMed ID: 26874388
[TBL] [Abstract][Full Text] [Related]
5. Sustained efficacy of pulmonary artery pressure to guide adjustment of chronic heart failure therapy: complete follow-up results from the CHAMPION randomised trial.
Abraham WT; Stevenson LW; Bourge RC; Lindenfeld JA; Bauman JG; Adamson PB;
Lancet; 2016 Jan; 387(10017):453-61. PubMed ID: 26560249
[TBL] [Abstract][Full Text] [Related]
6. Effect of Optimizing Guideline-Directed Medical Therapy Before Discharge on Mortality and Heart Failure Readmission in Patients Hospitalized With Heart Failure With Reduced Ejection Fraction.
Yamaguchi T; Kitai T; Miyamoto T; Kagiyama N; Okumura T; Kida K; Oishi S; Akiyama E; Suzuki S; Yamamoto M; Yamaguchi J; Iwai T; Hijikata S; Masuda R; Miyazaki R; Hara N; Nagata Y; Nozato T; Matsue Y
Am J Cardiol; 2018 Apr; 121(8):969-974. PubMed ID: 29477488
[TBL] [Abstract][Full Text] [Related]
7. Wireless pulmonary artery pressure monitoring guides management to reduce decompensation in heart failure with preserved ejection fraction.
Adamson PB; Abraham WT; Bourge RC; Costanzo MR; Hasan A; Yadav C; Henderson J; Cowart P; Stevenson LW
Circ Heart Fail; 2014 Nov; 7(6):935-44. PubMed ID: 25286913
[TBL] [Abstract][Full Text] [Related]
8. Guideline-Directed Medical Therapy and Survival Following Hospitalization in Patients with Heart Failure.
Tran RH; Aldemerdash A; Chang P; Sueta CA; Kaufman B; Asafu-Adjei J; Vardeny O; Daubert E; Alburikan KA; Kucharska-Newton AM; Stearns SC; Rodgers JE
Pharmacotherapy; 2018 Apr; 38(4):406-416. PubMed ID: 29423950
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary Vascular Distensibility Predicts Pulmonary Hypertension Severity, Exercise Capacity, and Survival in Heart Failure.
Malhotra R; Dhakal BP; Eisman AS; Pappagianopoulos PP; Dress A; Weiner RB; Baggish AL; Semigran MJ; Lewis GD
Circ Heart Fail; 2016 Jun; 9(6):. PubMed ID: 27301469
[TBL] [Abstract][Full Text] [Related]
10. Comparative Effectiveness of Dosing of Medical Therapy for Heart Failure: From the CHAMP-HF Registry.
Greene SJ; Butler J; Hellkamp AS; Spertus JA; Vaduganathan M; Devore AD; Albert NM; Patterson JH; Thomas L; Williams FB; Hernandez AF; Fonarow GC
J Card Fail; 2022 Mar; 28(3):370-384. PubMed ID: 34793971
[TBL] [Abstract][Full Text] [Related]
11. Background pharmacological therapy in the ANTHEM-HF: comparison to contemporary trials of novel heart failure therapies.
Premchand RK; Sharma K; Mittal S; Monteiro R; Libbus I; Ardell JL; Gregory DD; KenKnight BH; Amurthur B; DiCarlo LA; Anand IS
ESC Heart Fail; 2019 Oct; 6(5):1052-1056. PubMed ID: 31339232
[TBL] [Abstract][Full Text] [Related]
12. Impact of Practice-Based Management of Pulmonary Artery Pressures in 2000 Patients Implanted With the CardioMEMS Sensor.
Heywood JT; Jermyn R; Shavelle D; Abraham WT; Bhimaraj A; Bhatt K; Sheikh F; Eichorn E; Lamba S; Bharmi R; Agarwal R; Kumar C; Stevenson LW
Circulation; 2017 Apr; 135(16):1509-1517. PubMed ID: 28219895
[TBL] [Abstract][Full Text] [Related]
13. Medical Therapy for Heart Failure With Reduced Ejection Fraction: The CHAMP-HF Registry.
Greene SJ; Butler J; Albert NM; DeVore AD; Sharma PP; Duffy CI; Hill CL; McCague K; Mi X; Patterson JH; Spertus JA; Thomas L; Williams FB; Hernandez AF; Fonarow GC
J Am Coll Cardiol; 2018 Jul; 72(4):351-366. PubMed ID: 30025570
[TBL] [Abstract][Full Text] [Related]
14. Safety and feasibility of pulmonary artery pressure-guided heart failure therapy: rationale and design of the prospective CardioMEMS Monitoring Study for Heart Failure (MEMS-HF).
Angermann CE; Assmus B; Anker SD; Brachmann J; Ertl G; Köhler F; Rosenkranz S; Tschöpe C; Adamson PB; Böhm M
Clin Res Cardiol; 2018 Nov; 107(11):991-1002. PubMed ID: 29777373
[TBL] [Abstract][Full Text] [Related]
15. Heart Failure Hospitalization and Guideline-Directed Prescribing Patterns Among Heart Failure With Reduced Ejection Fraction Patients.
Srivastava PK; DeVore AD; Hellkamp AS; Thomas L; Albert NM; Butler J; Patterson JH; Spertus JA; Williams FB; Duffy CI; Hernandez AF; Fonarow GC
JACC Heart Fail; 2021 Jan; 9(1):28-38. PubMed ID: 33309579
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of medical therapy in patients with heart failure with reduced ejection fraction.
Kocabaş U; Ergin I; Kıvrak T; Yılmaz Öztekin GM; Tanık VO; Özdemir İ; Avcı Demir F; Doğduş M; Şen T; Altınsoy M; Üstündağ S; Urgun ÖD; Sinan ÜY; Uygur B; Yeni M; Özçalık E
ESC Heart Fail; 2023 Dec; 10(6):3677-3689. PubMed ID: 37804042
[TBL] [Abstract][Full Text] [Related]
17. Remote Hemodynamic-Guided Therapy of Patients With Recurrent Heart Failure Following Cardiac Resynchronization Therapy.
Varma N; Bourge RC; Stevenson LW; Costanzo MR; Shavelle D; Adamson PB; Ginn G; Henderson J; Abraham WT;
J Am Heart Assoc; 2021 Feb; 10(5):e017619. PubMed ID: 33626889
[TBL] [Abstract][Full Text] [Related]
18. Discharge treatment with angiotensin-converting enzyme inhibitor/angiotensin receptor blocker after a heart failure hospitalisation is associated with a better prognosis irrespective of left ventricular ejection fraction.
Vicent L; Cinca J; Vazquez-García R; Gonzalez-Juanatey JR; Rivera M; Segovia J; Pascual-Figal D; Bover R; Worner F; Delgado-Jiménez J; Fernández-Avilés F; Martínez-Sellés M
Intern Med J; 2019 Dec; 49(12):1505-1513. PubMed ID: 30887642
[TBL] [Abstract][Full Text] [Related]
19. Heart failure progression and mortality in atrial fibrillation patients with preserved or reduced left ventricular ejection fraction.
Slee A; Saad M; Saksena S
J Interv Card Electrophysiol; 2019 Sep; 55(3):325-331. PubMed ID: 30887281
[TBL] [Abstract][Full Text] [Related]
20. Recovered heart failure with reduced ejection fraction and outcomes: a prospective study.
Lupón J; Díez-López C; de Antonio M; Domingo M; Zamora E; Moliner P; González B; Santesmases J; Troya MI; Bayés-Genís A
Eur J Heart Fail; 2017 Dec; 19(12):1615-1623. PubMed ID: 28387002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
